President Donald Trump will deliver a speech on April 26 focused on ways to lower prescription drug prices, but the pharmaceutical industry doesn’t expect it to include the more dramatic reforms Trump espoused on the campaign trail.

The American Board of Radiology (ABR) made significant changes to its certification program for diagnostic radiologists in recent years, removing the oral component of the exam and relying on a standardized format with multiple-choice questions. This shift toward psychometric testing has made the certification program less reliable, according to a new analysis published by the Journal of the American College of Radiology, and the ABR should consider working with various stakeholders and education experts to change it.

Amazon has reportedly shelved plans to sell and distribute pharmaceuticals to hospitals and health systems through its Amazon Business unit, a move which analysts said illustrates the difficulty outside companies face in disrupting the existing healthcare supply chain.

The American College of Radiology (ACR) announced this week it is celebrating the 10-year anniversary of its National Radiology Data Registry (NRDR).

A study published April 12 in the Journal of General Internal Medicine found that screening patients for diabetes based on only age and weight could be missing more than half of high-risk patients.

A team of researchers examined diagnostic imaging utilization trends in Massachusetts from 2009 to 2013 for a recent study in the Journal of the American College of Radiology.

Twitter holds the potential to disseminate bite-sized snippets of medical information to a diverse audience with little effort, but radiologists aren’t using the micro-blogging platform to its full capacity, according to research published in the Journal of the American College of Radiology.

After at least 10 patients received improper diagnoses owed to pathology lab errors, Winston Salem, N.C.-based Wake Forest Baptist Medical Center has been reviewing 9,291 cases ahead of a June deadline set by CMS that could strip its Medicare certification.